DRUG BINDING INTERFACES MAPPED TO 'PROTEASOME SUBUNIT BETA TYPE-7'
List of Binding Interfaces
(Click on the entry ID to view details of interfaces and pattern clusters)
(Note that ASSAM search use only 3-12 residue containing patterns)
Filter list by:
All hits
Sort hits by ligand
Sort hits by residue numbers
Only hits with patterns containing 3-12 residues
DrReposER ID
PDB
Ligand
Organism
Macromolecule
Pfam
Res.
Interface
HETATM
5LF3_B_BO2B305
5lf3
BO2
DB00188(Bortezomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation
14
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45SER b 46GLY b 47ALA b 49THR b 52MET b 95TYR V 114SER V 118SER b 169
BO2 b 305
5LF3_H_BO2H306
5lf3
BO2
DB00188(Bortezomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7
PF00227(Proteasome)PF12465(Pr_beta_C)
10
THR H 1ALA H 20THR H 21GLU H 22CYS H 31ALA H 46GLY H 47ALA H 49THR H 52ASP I 124
BO2 H 306
5LF3_N_BO2N304
5lf3
BO2
DB00188(Bortezomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7
PF00227(Proteasome)PF12465(Pr_beta_C)
14
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45SER N 46GLY N 47ALA N 49THR N 52MET N 95TYR H 114SER H 118SER N 169
BO2 N 304
5LF3_V_BO2V303
5lf3
BO2
DB00188(Bortezomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7
no annotation
10
THR V 1ALA V 20THR V 21GLU V 22LYS V 33ALA V 46GLY V 47ALA V 49THR V 52ASP W 124
BO2 V 303
5LF7_B_6V8B304
5lf7
6V8
DB09570(Ixazomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7
NonePF00227(Proteasome)PF10584(Proteasome_A_N)
12
THR b 2THR b 21THR b 22THR b 23ALA b 28LYS b 34ARG b 46SER b 47GLY b 48ALA b 50THR b 53TYR V 115
6V8 b 304
5LF7_H_6V8H305
5lf7
6V8
DB09570(Ixazomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7
PF00227(Proteasome)PF00227(Proteasome)PF12465(Pr_beta_C)
11
THR H 2ALA H 21THR H 22GLU H 23CYS H 32ALA H 47GLY H 48ALA H 50THR H 53ASP I 124LEU I 125
6V8 H 305
5LF7_N_6V8N305
5lf7
6V8
DB09570(Ixazomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7
PF00227(Proteasome)PF00227(Proteasome)PF12465(Pr_beta_C)
12
THR N 2THR N 21THR N 22THR N 23ALA N 28LYS N 34ARG N 46SER N 47GLY N 48ALA N 50THR N 53TYR H 115
6V8 N 305
5LF7_V_6V8V303
5lf7
6V8
DB09570(Ixazomib)
Homo sapiens
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7
None
11
THR V 2ALA V 21THR V 22GLU V 23CYS V 32ALA V 47GLY V 48ALA V 50THR V 53ASP W 124LEU W 125
6V8 V 303
[["5LF3_B_BO2B305","5lf3","BO2","DB00188(Bortezomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","PF00227(Proteasome);PF10584(Proteasome_A_N);no annotation",14,"THR b 1;THR b 20;THR b 21;THR b 22;LYS b 33;ARG b 45;SER b 46;GLY b 47;ALA b 49;THR b 52;MET b 95;TYR V 114;SER V 118;SER b 169","BO2 b 305\r"],["5LF3_H_BO2H306","5lf3","BO2","DB00188(Bortezomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","PF00227(Proteasome);PF12465(Pr_beta_C)",10,"THR H 1;ALA H 20;THR H 21;GLU H 22;CYS H 31;ALA H 46;GLY H 47;ALA H 49;THR H 52;ASP I 124","BO2 H 306\r"],["5LF3_N_BO2N304","5lf3","BO2","DB00188(Bortezomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","PF00227(Proteasome);PF12465(Pr_beta_C)",14,"THR N 1;THR N 20;THR N 21;THR N 22;LYS N 33;ARG N 45;SER N 46;GLY N 47;ALA N 49;THR N 52;MET N 95;TYR H 114;SER H 118;SER N 169","BO2 N 304\r"],["5LF3_V_BO2V303","5lf3","BO2","DB00188(Bortezomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","no annotation",10,"THR V 1;ALA V 20;THR V 21;GLU V 22;LYS V 33;ALA V 46;GLY V 47;ALA V 49;THR V 52;ASP W 124","BO2 V 303\r"],["5LF7_B_6V8B304","5lf7","6V8","DB09570(Ixazomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","None;PF00227(Proteasome);PF10584(Proteasome_A_N)",12,"THR b 2;THR b 21;THR b 22;THR b 23;ALA b 28;LYS b 34;ARG b 46;SER b 47;GLY b 48;ALA b 50;THR b 53;TYR V 115","6V8 b 304\r"],["5LF7_H_6V8H305","5lf7","6V8","DB09570(Ixazomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","PF00227(Proteasome);PF00227(Proteasome);PF12465(Pr_beta_C)",11,"THR H 2;ALA H 21;THR H 22;GLU H 23;CYS H 32;ALA H 47;GLY H 48;ALA H 50;THR H 53;ASP I 124;LEU I 125","6V8 H 305\r"],["5LF7_N_6V8N305","5lf7","6V8","DB09570(Ixazomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-6;PROTEASOME SUBUNIT BETA TYPE-7","PF00227(Proteasome);PF00227(Proteasome);PF12465(Pr_beta_C)",12,"THR N 2;THR N 21;THR N 22;THR N 23;ALA N 28;LYS N 34;ARG N 46;SER N 47;GLY N 48;ALA N 50;THR N 53;TYR H 115","6V8 N 305\r"],["5LF7_V_6V8V303","5lf7","6V8","DB09570(Ixazomib)","Homo sapiens","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","None",11,"THR V 2;ALA V 21;THR V 22;GLU V 23;CYS V 32;ALA V 47;GLY V 48;ALA V 50;THR V 53;ASP W 124;LEU W 125","6V8 V 303\r"]]